Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1666)	2/13/2002 5:47:32 PM
From: Robohogs	Respond to of 10345

<< Moodys might be right in their evaluation of the company's progress seen from a bond-holders point of view. That is however to most investors in biotech shares not a very interesting view of the business. >> Agreed. I was just trying to explain the downgrade. I am actually happy to see it. I had posted last week or the week before that this would happen, and it finally did. Now time to buy, buy, buy. This is the proverbial last shoe to drop (I hope). I will now go full out. My view: 1. They drew down debt so this downgrade does not hurt them so bad except that converts are now real debt with stock out of bounds 2. Lawsuits will not suck that much money out at the end of the day 3. Earnings will clean up 4. They will buy revenue soon Jon